PT1521573E - Composições de implantes farmacêuticos lipofílicos não poliméricos para utilização intra-ocular - Google Patents

Composições de implantes farmacêuticos lipofílicos não poliméricos para utilização intra-ocular Download PDF

Info

Publication number
PT1521573E
PT1521573E PT03764334T PT03764334T PT1521573E PT 1521573 E PT1521573 E PT 1521573E PT 03764334 T PT03764334 T PT 03764334T PT 03764334 T PT03764334 T PT 03764334T PT 1521573 E PT1521573 E PT 1521573E
Authority
PT
Portugal
Prior art keywords
implant compositions
intraocular use
lipophilic pharmaceutical
pharmaceutical implant
polymeric
Prior art date
Application number
PT03764334T
Other languages
English (en)
Inventor
Bhagwati P Kabra
Janet D Howie
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Inc filed Critical Alcon Inc
Publication of PT1521573E publication Critical patent/PT1521573E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
PT03764334T 2002-07-15 2003-06-30 Composições de implantes farmacêuticos lipofílicos não poliméricos para utilização intra-ocular PT1521573E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39584002P 2002-07-15 2002-07-15

Publications (1)

Publication Number Publication Date
PT1521573E true PT1521573E (pt) 2008-02-08

Family

ID=30115932

Family Applications (1)

Application Number Title Priority Date Filing Date
PT03764334T PT1521573E (pt) 2002-07-15 2003-06-30 Composições de implantes farmacêuticos lipofílicos não poliméricos para utilização intra-ocular

Country Status (18)

Country Link
US (2) US7678827B2 (pt)
EP (1) EP1521573B1 (pt)
JP (1) JP4463681B2 (pt)
KR (1) KR101003518B1 (pt)
CN (1) CN100355455C (pt)
AT (1) ATE382330T1 (pt)
AU (1) AU2003248777B2 (pt)
BR (1) BR0312635A (pt)
CA (1) CA2491313C (pt)
CY (1) CY1107166T1 (pt)
DE (1) DE60318446T2 (pt)
DK (1) DK1521573T3 (pt)
ES (1) ES2295647T3 (pt)
MX (1) MXPA05000632A (pt)
PL (1) PL206594B1 (pt)
PT (1) PT1521573E (pt)
WO (1) WO2004006890A1 (pt)
ZA (2) ZA200410095B (pt)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6955661B1 (en) * 1999-01-25 2005-10-18 Atrium Medical Corporation Expandable fluoropolymer device for delivery of therapeutic agents and method of making
US7947015B2 (en) * 1999-01-25 2011-05-24 Atrium Medical Corporation Application of a therapeutic substance to a tissue location using an expandable medical device
US7431710B2 (en) 2002-04-08 2008-10-07 Glaukos Corporation Ocular implants with anchors and methods thereof
US20070184089A1 (en) * 2002-07-15 2007-08-09 Alcon, Inc. Non-Polymeric Lipophilic Pharmaceutical Implant Compositions for Intraocular Use
US7678827B2 (en) * 2002-07-15 2010-03-16 Alcon, Inc. Non-polymeric lipophilic pharmaceutical implant compositions for intraocular use
US20050244463A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Sustained release intraocular implants and methods for treating ocular vasculopathies
JP5097883B2 (ja) * 2004-09-02 2012-12-12 株式会社 神崎高級工機製作所 油圧駆動車両
US20060067976A1 (en) 2004-09-28 2006-03-30 Atrium Medical Corporation Formation of barrier layer
US9000040B2 (en) 2004-09-28 2015-04-07 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US9012506B2 (en) 2004-09-28 2015-04-21 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
ATE425740T1 (de) * 2005-09-21 2009-04-15 Univ Aston Chronotherapeutisches okulares abgabesystem aus einer kombination von prostaglandinen und einem betablocker zur behandlung von primarem glaukom
US9278161B2 (en) 2005-09-28 2016-03-08 Atrium Medical Corporation Tissue-separating fatty acid adhesion barrier
US9427423B2 (en) 2009-03-10 2016-08-30 Atrium Medical Corporation Fatty-acid based particles
US9474645B2 (en) * 2006-06-21 2016-10-25 Johnson & Johnson Vision Care, Inc. Punctal plugs for the delivery of active agents
US20080045911A1 (en) * 2006-06-21 2008-02-21 Borgia Maureen J Punctal plugs for the delivery of active agents
US9173773B2 (en) * 2006-06-21 2015-11-03 Johnson & Johnson Vision Care, Inc. Punctal plugs for the delivery of active agents
UY30883A1 (es) 2007-01-31 2008-05-31 Alcon Res Tapones punctales y metodos de liberacion de agentes terapeuticos
MX2010002616A (es) * 2007-09-07 2010-08-04 Qlt Plug Delivery Inc Nucleos de farmaco para la liberacion sostenida de agentes terapeuticos.
TWI451862B (zh) * 2007-10-09 2014-09-11 Alcon Res Ltd 用於眼睛注射的熱係數驅動藥丸尺寸
TWI498136B (zh) * 2007-10-09 2015-09-01 Alcon Res Ltd 用於遞送速率及溫度相依性物質至眼睛的注射器及其製備方法
JP2010104632A (ja) 2008-10-31 2010-05-13 Hoya Corp ゲル化能を有する眼科用組成物
US9095506B2 (en) 2008-11-17 2015-08-04 Allergan, Inc. Biodegradable alpha-2 agonist polymeric implants and therapeutic uses thereof
US8632511B2 (en) * 2009-05-06 2014-01-21 Alcon Research, Ltd. Multiple thermal sensors in a multiple processor environment for temperature control in a drug delivery device
US10206813B2 (en) 2009-05-18 2019-02-19 Dose Medical Corporation Implants with controlled drug delivery features and methods of using same
US20110038910A1 (en) 2009-08-11 2011-02-17 Atrium Medical Corporation Anti-infective antimicrobial-containing biomaterials
CN102724951A (zh) 2009-11-09 2012-10-10 阿勒根公司 用于刺激毛发生长的组合物和方法
DK2515887T3 (en) * 2009-12-22 2018-09-17 Ucb Biopharma Sprl Polyvinylpyrrolidone to stabilize a solid dispersion of the non-crystalline form of rotigotine
US8177747B2 (en) * 2009-12-22 2012-05-15 Alcon Research, Ltd. Method and apparatus for drug delivery
WO2012009707A2 (en) 2010-07-16 2012-01-19 Atrium Medical Corporation Composition and methods for altering the rate of hydrolysis of cured oil-based materials
DE102011016277B4 (de) * 2011-04-06 2013-02-21 Heraeus Medical Gmbh Plastisch verformbares, biodegradierbares Hämostyptikum und Verfahren zum Formen eines solchen
US9867880B2 (en) 2012-06-13 2018-01-16 Atrium Medical Corporation Cured oil-hydrogel biomaterial compositions for controlled drug delivery
CA2901280A1 (en) 2013-02-15 2014-08-21 Allergan, Inc. Sustained drug delivery implant
JP2015086222A (ja) * 2013-09-26 2015-05-07 参天製薬株式会社 安定化された２−アミノ−３−（４−ブロモベンゾイル）フェニル酢酸含有水性組成物
EP3148491B1 (en) 2014-05-29 2020-07-01 Glaukos Corporation Implants with controlled drug delivery features and manufacturing method for said implants
WO2017040853A1 (en) 2015-09-02 2017-03-09 Glaukos Corporation Drug delivery implants with bi-directional delivery capacity
US11564833B2 (en) 2015-09-25 2023-01-31 Glaukos Corporation Punctal implants with controlled drug delivery features and methods of using same
CA3022830A1 (en) 2016-04-20 2017-10-26 Harold Alexander Heitzmann Bioresorbable ocular drug delivery device
KR20190061047A (ko) * 2016-09-30 2019-06-04 마티 테라퓨틱스 인코포레이티드 안과 약제의 서방성 제형 및 그 용도
EP3638705B1 (en) 2017-06-13 2024-02-28 Alcon Inc. Intraocular lens compositions
RU2675691C1 (ru) * 2017-09-14 2018-12-21 Федеральное Государственное бюджетное образовательное учреждение высшего образования Дагестанский государственный медицинский университет Министерства здравоохранения Российской Федерации Способ длительной перфузии субтенонового пространства лекарственными средствами

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4014335A (en) * 1975-04-21 1977-03-29 Alza Corporation Ocular drug delivery device
JPS6042766B2 (ja) * 1978-12-09 1985-09-25 日本化薬株式会社 基剤
US4797288A (en) * 1984-10-05 1989-01-10 Warner-Lambert Company Novel drug delivery system
GB8524421D0 (en) * 1985-10-03 1985-11-06 Boots Co Plc Therapeutic agents
US4853224A (en) * 1987-12-22 1989-08-01 Visionex Biodegradable ocular implants
US4997652A (en) * 1987-12-22 1991-03-05 Visionex Biodegradable ocular implants
JP2893191B2 (ja) * 1988-11-08 1999-05-17 武田薬品工業株式会社 放出制御性マトリックス剤
US5015474A (en) * 1988-11-22 1991-05-14 Parnell Pharmaceuticals, Inc. Composition for imparting moisture to a substrate
AU639228B2 (en) * 1989-02-17 1993-07-22 Transave, Inc. Lipid excipient for nasal delivery and topical application
US5164188A (en) * 1989-11-22 1992-11-17 Visionex, Inc. Biodegradable ocular implants
US5660851A (en) * 1989-12-26 1997-08-26 Yissum Research Development Company Of The Hebrew Univ. Of Jerusalem Ocular inserts
US5474780A (en) 1990-04-27 1995-12-12 Allergan, Inc. Monolithic maleic anhydride drug delivery systems
IE65045B1 (en) 1990-04-28 1995-10-04 Takeda Chemical Industries Ltd Granulated preparations and method of producing the same
US5378475A (en) * 1991-02-21 1995-01-03 University Of Kentucky Research Foundation Sustained release drug delivery devices
WO1992020334A1 (en) * 1991-05-13 1992-11-26 The Boots Company Plc Pharmaceutical composition comprising ibuprofen salt
US5629019A (en) * 1992-02-27 1997-05-13 Alza Corporation Formulations with hydrophobic permeation enhancers
US5178635A (en) * 1992-05-04 1993-01-12 Allergan, Inc. Method for determining amount of medication in an implantable device
WO1994005257A1 (en) 1992-09-08 1994-03-17 Allergan, Inc. Sustained release of ophthalmic drugs from a soluble polymer drug delivery vehicle
WO1995003009A1 (en) * 1993-07-22 1995-02-02 Oculex Pharmaceuticals, Inc. Method of treatment of macular degeneration
US5433951A (en) * 1993-10-13 1995-07-18 Bristol-Myers Squibb Company Sustained release formulation containing captopril and method
US5443505A (en) * 1993-11-15 1995-08-22 Oculex Pharmaceuticals, Inc. Biocompatible ocular implants
US5773021A (en) 1994-03-14 1998-06-30 Vetoquinol S.A. Bioadhesive ophthalmic insert
CA2119109C (en) 1994-03-15 2002-11-12 Florian Gurtler Bioadhesive ophthalmic insert
DK1125577T3 (da) 1994-04-08 2006-06-19 Qlt Usa Inc Væskeformige medikamentindföringspræparater
US6190691B1 (en) 1994-04-12 2001-02-20 Adolor Corporation Methods for treating inflammatory conditions
US5466233A (en) * 1994-04-25 1995-11-14 Escalon Ophthalmics, Inc. Tack for intraocular drug delivery and method for inserting and removing same
AUPM897594A0 (en) 1994-10-25 1994-11-17 Daratech Pty Ltd Controlled release container
ATE232089T1 (de) 1994-11-10 2003-02-15 Univ Kentucky Res Found Implantierbare wiederauffüllbare vorrichtung mit gesteuerter freisetzung zur verabreichung von arzneistoffen unmittelbar an einen inneren teil des körpers
US5725493A (en) 1994-12-12 1998-03-10 Avery; Robert Logan Intravitreal medicine delivery
US5718922A (en) * 1995-05-31 1998-02-17 Schepens Eye Research Institute, Inc. Intravitreal microsphere drug delivery and method of preparation
US5869079A (en) 1995-06-02 1999-02-09 Oculex Pharmaceuticals, Inc. Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
US5773019A (en) 1995-09-27 1998-06-30 The University Of Kentucky Research Foundation Implantable controlled release device to deliver drugs directly to an internal portion of the body
US5736152A (en) 1995-10-27 1998-04-07 Atrix Laboratories, Inc. Non-polymeric sustained release delivery system
EP0862916B1 (en) 1995-11-20 2003-03-05 Kiyoshi Kita topical use of vitamin D for the treatment of eye disorders
US5797898A (en) 1996-07-02 1998-08-25 Massachusetts Institute Of Technology Microchip drug delivery devices
WO1998040051A1 (en) * 1997-03-12 1998-09-17 Abbott Laboratories Lipophilic binary systems for the administration of lipophilic compounds
US6143276A (en) 1997-03-21 2000-11-07 Imarx Pharmaceutical Corp. Methods for delivering bioactive agents to regions of elevated temperatures
US6120751A (en) 1997-03-21 2000-09-19 Imarx Pharmaceutical Corp. Charged lipids and uses for the same
EP1003569B1 (en) 1997-08-11 2004-10-20 Allergan, Inc. Sterile bioerodible implant device containing retinoid with improved biocompatability and method of manufacture
US5902598A (en) 1997-08-28 1999-05-11 Control Delivery Systems, Inc. Sustained release drug delivery devices
IL121647A (en) * 1997-08-28 2001-07-24 Pharmateam Dev Ltd Pharmaceutical compositions for the treatment of ocular inflammation comprising dexamethasone palmitate
US6099853A (en) * 1997-09-04 2000-08-08 Protein Express Vaginal suppository vaccine for urogenital infections
US5891476A (en) * 1997-12-22 1999-04-06 Reo; Joe P. Tastemasked pharmaceutical system
DE19804310A1 (de) * 1998-02-04 1999-08-05 Aventis Res & Tech Gmbh & Co Spiroverbindungen und deren Verwendung
DE10030378A1 (de) * 2000-06-21 2002-03-14 Audit Inst For Medical Service Neue pharmazeutische Zusammensetzung zur topischen Anwendung von wasserunlöslichen und/oder schwer wasserlöslichen Wirkstoffen
AU6608701A (en) * 2000-06-21 2002-01-02 Audit Institute For Medical Services And Quality Assurance Gmbh Pharmaceutical preparations containing cyclosporines and neutral oils
AR038628A1 (es) 2002-03-04 2005-01-19 Novartis Ag Composicion oftalmica
US7678827B2 (en) * 2002-07-15 2010-03-16 Alcon, Inc. Non-polymeric lipophilic pharmaceutical implant compositions for intraocular use
US7297709B2 (en) * 2003-05-22 2007-11-20 Abbott Laboratories Indazole, benzisoxazole, and benzisothiazole kinase inhibitors

Also Published As

Publication number Publication date
AU2003248777A1 (en) 2004-02-02
MXPA05000632A (es) 2005-03-31
ATE382330T1 (de) 2008-01-15
BR0312635A (pt) 2005-04-19
KR20050023409A (ko) 2005-03-09
WO2004006890A1 (en) 2004-01-22
AU2003248777B2 (en) 2008-02-14
ZA200410096B (en) 2006-07-26
DE60318446T2 (de) 2008-05-21
CA2491313C (en) 2011-05-24
DE60318446D1 (de) 2008-02-14
ZA200410095B (en) 2006-07-26
US20040013704A1 (en) 2004-01-22
KR101003518B1 (ko) 2010-12-30
CN1668277A (zh) 2005-09-14
JP4463681B2 (ja) 2010-05-19
EP1521573B1 (en) 2008-01-02
US7678827B2 (en) 2010-03-16
JP2006500328A (ja) 2006-01-05
CA2491313A1 (en) 2004-01-22
PL374743A1 (en) 2005-10-31
US8178576B2 (en) 2012-05-15
CN100355455C (zh) 2007-12-19
DK1521573T3 (da) 2008-03-25
CY1107166T1 (el) 2012-10-24
ES2295647T3 (es) 2008-04-16
US20080241224A1 (en) 2008-10-02
EP1521573A1 (en) 2005-04-13
PL206594B1 (pl) 2010-08-31

Similar Documents

Publication Publication Date Title
PT1521573E (pt) Composições de implantes farmacêuticos lipofílicos não poliméricos para utilização intra-ocular
AU2003213719A8 (en) Multiple-component solid phases containing at least one active pharmaceutical ingredient
GB2389530B (en) Pharmaceutical compositions
TWI328576B (en) Diketohydrazine derivative compound, medicament containing same as active ingredient
ZA200410216B (en) Package for surgical implant.
IL166483A0 (en) Pharmaceutical compositions containing ciclesonideand an antihistamine
GB2391473B (en) Pharmaceutical compositions
EP1547548A3 (en) Junction for a modular implant
PT1121127E (pt) Composicoes farmaceuticas orais contendo buprenorfina
NO20064808L (no) Orale matrixformuleringer med licarbazepin
AU2002309038A1 (en) Compositions for transmucosal administration containing coenzyme Q as the active ingredient
ZA200604874B (en) Pharmaceutical compositions
EP1534353A4 (en) ORTHOPEDIC MATERIALS DERIVED FROM KERATIN
TW200531686A (en) Pharmaceutical compositions
GB0213481D0 (en) Pharmaceutical compositions
EP1480649A4 (en) STABLE PHARMACEUTICAL COMPOSITIONS
HU0304095D0 (en) Novel, effective pharmaceutical compositions
SI1521573T1 (sl) Nepolimerni lipofilni farmacevtski implantatni sestavki za intraokularno uporabo
ZA200204905B (en) Improved pharmaceutical dental formulations.
IT1307221B1 (it) Dispositivo di collegamento a vite, particolarmente per impiantiosteointegrati, ad esempio per impianti dentali.
ES1053198Y (es) Implante dental.
GB2397226B (en) Natural ingredient tooth powder
ITTO20010526A0 (it) Vite implantare per protesi dentaria.
ITTO20010528A0 (it) Vite implantare per protesi dentaria.
ZA200304401B (en) Dental implant.